Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ruthenium catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104059009A reveals asymmetric ruthenium catalysis for Ezetimibe intermediate ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturers.
Novel graphene-supported ruthenium catalyst method ensures high purity and selectivity for polymer and specialty chemical manufacturing supply chains.
Novel ruthenium complex synthesis patent CN105440085A offers high purity and selectivity for antitumor drug manufacturing supply chain efficiency.
Patent CN105085189A details a robust aprotic solvent method for chiral alcohol synthesis, offering significant supply chain stability and cost reduction for pharmaceutical intermediates.
Efficient asymmetric Michael addition for pharmaceutical intermediates using novel Ru-diamine complexes. Reduces cost and improves purity for API manufacturing.
Patent CN111170829B details a safer, high-selectivity route for hexamethylindanol using supported Ru catalysts, offering significant cost and safety advantages for fragrance manufacturers.
Patent CN1360574A details a novel route for tricyclic aminoalcohol derivatives featuring asymmetric reduction. This process offers significant cost reduction and improved supply chain reliability for pharmaceutical manufacturing.
Patent CN107892698B details a solvent-free ruthenium catalyzed selective borylation method offering cost reduction and high purity for pharmaceutical intermediate manufacturing.
Patent CN106349295B reveals mild ruthenium catalysis for nitrobenzene reduction offering supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN1968927B details a novel Ru-catalyzed route for high-purity quinoline intermediates used in bronchodilators, offering significant cost reduction in API manufacturing.
Patent CN101941900A reveals a novel Ru-catalyzed asymmetric hydrogenation route for high-purity chiral acids, offering significant cost reduction in API manufacturing and enhanced supply chain stability.
Patent CN105622363B enables one-step vanillyl alcohol ether production. Dual catalyst system ensures high purity and supply chain stability for global buyers.
Novel catalytic method for imidazolone compounds ensures high yield and purity. Ideal for pharmaceutical intermediates supply chain optimization and cost reduction.
Patent CN104245649A details Ru-catalyzed Guerbet alcohol production offering cost reduction and high-purity surfactant intermediates for supply chain reliability.
Patent CN104910034A details a novel ruthenium-catalyzed synthesis for high-purity alpha-beta-diamino acid derivatives, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN115108932A reveals a novel Ru-catalyzed oxidative amidation using DMF. This method offers significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN106588746B reveals a green hydrogenation route for Gliclazide side chain. Offers high purity, catalyst recycling, and cost reduction for pharmaceutical manufacturing.
Patent CN118084876A reveals a concise Pauson-Khand route for indole skeletons. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Patent CN111499538A details a novel Ru-C3*-Tunephos catalytic system for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable manufacturing solutions.
Novel patent CN114380736B details efficient synthesis of 2,3,4,5-tetrahydropyridine compounds using pincer ruthenium catalysts, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.